Vr Adviser, LLC Erasca, Inc. Transaction History
Vr Adviser, LLC
- $414 Million
- Q1 2025
A detailed history of Vr Adviser, LLC transactions in Erasca, Inc. stock. As of the latest transaction made, Vr Adviser, LLC holds 16,216,216 shares of ERAS stock, worth $23 Million. This represents 5.36% of its overall portfolio holdings.
Number of Shares
16,216,216
Previous 16,216,216
-0.0%
Holding current value
$23 Million
Previous $40.7 Million
45.42%
% of portfolio
5.36%
Previous 6.72%
Shares
1 transactions
Others Institutions Holding ERAS
# of Institutions
163Shares Held
222MCall Options Held
20.6KPut Options Held
5.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA22.6MShares$32.1 Million1.95% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD17.3MShares$24.6 Million0.02% of portfolio
-
Logos Global Management LP San Francisco, CA13MShares$18.5 Million3.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$18.1 Million0.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY12.3MShares$17.5 Million0.74% of portfolio
About Erasca, Inc.
- Ticker ERAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 122,147,000
- Market Cap $173M
- Description
- Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...